A step toward advancing precision hormone therapies to reduce Alzheimer's risk

When it comes to post-menopausal hormone therapy, the type, route and duration all play a role in reducing the risk of neurodegenerative diseases.

from Women's Health News -- ScienceDaily https://ift.tt/3yRJZRp

A step toward advancing precision hormone therapies to reduce Alzheimer's risk

When it comes to post-menopausal hormone therapy, the type, route and duration all play a role in reducing the risk of neurodegenerative diseases.

from Women's Health News -- ScienceDaily https://ift.tt/3yRJZRp

The shape of nanoparticles in body fluids may help identify the type of cancer

A recent study has shown that the shape of cell-derived nanoparticles, known as 'extracellular vesicles' (EVs), in body fluids could be a biomarker for identifying types of cancer. In the study, scientists successfully measured the shape distributions of EVs derived from liver, breast, and colorectal cancer cells, showing that the shape distributions differ from one another.

from Breast Cancer News -- ScienceDaily https://ift.tt/3xwc4xu

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

GluN3A-deficient mice display all aspects of Alzheimer's neurodegeneration.

from Women's Health News -- ScienceDaily https://ift.tt/3A8eBQo

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

GluN3A-deficient mice display all aspects of Alzheimer's neurodegeneration.

from Women's Health News -- ScienceDaily https://ift.tt/3A8eBQo

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Women's Health News -- ScienceDaily https://ift.tt/3daspzI

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Breast Cancer News -- ScienceDaily https://ift.tt/3daspzI

Drug doubles down on bone cancer, metastasis

Researchers develop an antibody conjugate called BonTarg that delivers drugs to bone tumors and inhibits metastasis.

from Women's Health News -- ScienceDaily https://ift.tt/3daspzI

Fertility drugs do not increase breast cancer risk, study finds

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

from Breast Cancer News -- ScienceDaily https://ift.tt/3xJT8uN

Fertility drugs do not increase breast cancer risk, study finds

Drugs routinely used during fertility treatments to release eggs do not increase the risk of developing breast cancer, new research has shown.

from Women's Health News -- ScienceDaily https://ift.tt/3xJT8uN